Is BPSR or JNJ a better dividend investment in 2026?

BPSR currently yields 3333.33% with a 5% 5-year dividend growth rate. JNJ yields 2.14% with 5.8% growth. The better choice depends on your goal: BPSR offers higher current income.

What is the dividend yield difference between BPSR and JNJ?

BPSR has a forward dividend yield of 3333.33% ($2.00/share annually). JNJ yields 2.14% ($5.20/share annually). The yield gap is 3331.19 percentage points.

Home › Compare › BPSR vs JNJ

BPSR vs JNJ: Dividend Comparison 2026

BPSR yields 3333.33% · JNJ yields 2.14%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 BPSR wins by $1244041712890.37M in total portfolio value

INVESTMENT

TIME HORIZON10 years

BPSR

● Live price

3333.33%

Share price

$0.06

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$1244041712890.40M

Annual income

$1,174,716,366,071,938,000.00

Full BPSR calculator →

JNJ

Johnson & Johnson

● Live price

2.14%

Share price

$242.49

Annual div

$5.20

5Y div CAGR

28%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$30.5K

Annual income

$4,749.88

Full JNJ calculator →

Portfolio growth — BPSR vs JNJ

📍 BPSR pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	BPSR	JNJ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, BPSR + JNJ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

BPSR pays

JNJ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BPSR

Annual income on $10K today (after 15% tax)

$283,333.33/yr

After 10yr DRIP, annual income (after tax)

$998,508,911,161,147,300.00/yr

JNJ

Annual income on $10K today (after 15% tax)

$182.28/yr

After 10yr DRIP, annual income (after tax)

$4,037.40/yr

At 15% tax rate, BPSR beats the other by $998,508,911,161,143,200.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BPSR + JNJ for your $10,000?

BPSR: 50%JNJ: 50%

100% JNJ50/50100% BPSR

Portfolio after 10yr

$622020856445.21M

Annual income

$587,358,183,035,971,500.00/yr

Blended yield

94.43%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

BPSR

No analyst data

JNJ

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$228.73

-5.7% upside vs current

Range: $190.00 — $265.00

Altman Z

5.2

Piotroski

4/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BPSR buys

JNJ buys

No recent congressional trades found for BPSR or JNJ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricBPSRJNJ

Forward yield	3333.33% ✓	2.14%
Annual dividend / share	$2.00	$5.20 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	28% ✓
Portfolio after 10y	$1244041712890.40M ✓	$30.5K
Annual income after 10y	$1,174,716,366,071,938,000.00 ✓	$4,749.88
Total dividends collected	$1239274250481.68M ✓	$15.6K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: BPSR vs JNJ ($10,000, DRIP)

Year	BPSR Portfolio	BPSR Income/yr	JNJ Portfolio	JNJ Income/yr	Gap
1← crossover	$344,033	$333,333.33	$10,594	$274.49	+$333.4K → BPSR
2	$11,085,665	$10,717,549.33	$11,294	$360.69	+$11.07M → BPSR
3	$334,616,633	$322,754,971.08	$12,133	$476.91	+$334.60M → BPSR
4	$9,462,934,690	$9,104,894,892.71	$13,156	$635.42	+$9462.92M → BPSR
5	$250,766,259,005	$240,640,918,887.41	$14,432	$854.61	+$250766.24M → BPSR
6	$6,228,082,462,189	$5,959,762,565,053.11	$16,056	$1,162.76	+$6228082.45M → BPSR
7	$144,998,525,500,125	$138,334,477,265,582.72	$18,175	$1,604.53	+$144998525.48M → BPSR
8	$3,165,074,899,913,431	$3,009,926,477,628,297.00	$21,009	$2,252.68	+$3165074899.89M → BPSR
9	$64,790,043,755,570,470	$61,403,413,612,663,110.00	$24,911	$3,229.73	+$64790043755.55M → BPSR
10	$1,244,041,712,890,398,500	$1,174,716,366,071,938,000.00	$30,458	$4,749.88	+$1244041712890.37M → BPSR

BPSR vs JNJ: Complete Analysis 2026

BPSR — Stock

Organicell Regenerative Medicine, Inc. processes, distributes, and supplies biologically processed cellular and tissue-based products in the United States. The company was formerly known as Biotech Products Services and Research, Inc. and changed its name to Organicell Regenerative Medicine, Inc. in June 2018. Organicell Regenerative Medicine, Inc. has an agreement with Regenerative Care Network to study potential therapeutic benefits of Zofin for patients with heart failure. Organicell Regenerative Medicine, Inc. was founded in 2011 and is headquartered in Miami, Florida.

Full BPSR Calculator →

JNJ — Healthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →

📬

Get this BPSR vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BPSR vs SCHD BPSR vs JEPI BPSR vs O BPSR vs KO BPSR vs MAIN BPSR vs ABBV BPSR vs MRK BPSR vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.